Taigen Biopharmaceuticals Holdings Ltd (4157) — Net Asset Quality Index
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Net Asset Quality Index of 88.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.01 Billion minus total liabilities of NT$120.70 Million yields net assets of NT$892.68 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Taigen Biopharmaceuticals Holdings Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Taigen Biopharmaceuticals Holdings Ltd Net Asset Quality Index Over Time (2010–2024)
This chart shows how Taigen Biopharmaceuticals Holdings Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2010 to 2024. As of September 2025, the index stands at 88.1%, representing net assets of NT$892.68 Million against total assets of NT$1.01 Billion TWD. See working capital position of Taigen Biopharmaceuticals Holdings Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Taigen Biopharmaceuticals Holdings Ltd (2010–2024)
The table below presents the year-by-year Net Asset Quality Index for Taigen Biopharmaceuticals Holdings Ltd from 2010 to 2024, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 4157 stock market capitalisation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 92.2% | NT$1.08 Billion | NT$1.17 Billion | NT$91.96 Million | ▲ +1.2 pp |
| 2023 | 91.0% | NT$1.12 Billion | NT$1.23 Billion | NT$110.94 Million | ▼ -1.7 pp |
| 2022 | 92.6% | NT$970.03 Million | NT$1.05 Billion | NT$76.98 Million | ▲ +2.6 pp |
| 2021 | 90.0% | NT$1.25 Billion | NT$1.39 Billion | NT$139.11 Million | ▲ +10.5 pp |
| 2020 | 79.5% | NT$442.18 Million | NT$556.45 Million | NT$114.26 Million | ▼ -6.7 pp |
| 2019 | 86.2% | NT$815.18 Million | NT$946.11 Million | NT$130.92 Million | ▼ -5.9 pp |
| 2018 | 92.1% | NT$1.09 Billion | NT$1.19 Billion | NT$94.36 Million | ▼ -1.5 pp |
| 2017 | 93.6% | NT$1.42 Billion | NT$1.52 Billion | NT$97.71 Million | ▲ +11.5 pp |
| 2016 | 82.0% | NT$675.62 Million | NT$823.45 Million | NT$147.82 Million | ▲ +11.4 pp |
| 2015 | 70.6% | NT$441.60 Million | NT$625.46 Million | NT$183.86 Million | ▼ -7.0 pp |
| 2014 | 77.6% | NT$852.14 Million | NT$1.10 Billion | NT$246.05 Million | ▲ +46.0 pp |
| 2013 | 31.6% | NT$153.77 Million | NT$486.49 Million | NT$332.71 Million | ▼ -19.2 pp |
| 2012 | 50.8% | NT$372.80 Million | NT$733.95 Million | NT$361.15 Million | ▼ -33.3 pp |
| 2011 | 84.1% | NT$513.21 Million | NT$610.52 Million | NT$97.31 Million | ▲ +469.5 pp |
| 2010 | -385.4% | NT$-4.29 Billion | NT$1.11 Billion | NT$5.40 Billion | — |